To investigate the relationship between initial ClearSight™ derived hemodynamic parameters and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with acute infection and possible sepsis, with a focus on venous blood lactate (\< 2.0, 2.0-3.9, and ≥ 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic Group).
Study Type
OBSERVATIONAL
Enrollment
182
Noninvasive Hemodynamic Monitoring utilizing ClearSight TM System
Detroit Receiving Hospital
Detroit, Michigan, United States
RECRUITINGSinai-Grace Hospital
Detroit, Michigan, United States
RECRUITINGAscension St. John Hospital
Detroit, Michigan, United States
Composite outcome
Increase in modified Sequential Organ Failure Assessment (mSOFA) score ≥ 1 resulting in ICU admission / death.
Time frame: Within 72 hours of presentation
Venous Blood Lactate clearance
Venous Blood Lactate clearance
Time frame: Within 24 and 72 hours of presentation
Length of Stay
Emergency Department length of stay, ICU length of stay, and Hospital length of stay
Time frame: 30 days
Recidivism
Recidivism within 30 days of the index hospital visit
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Beaumont Hospital, Royal Oak
Royal Oak, Michigan, United States
TERMINATEDBeaumont Hospital, Troy
Troy, Michigan, United States
TERMINATED